Composition
- Active ingredients
- CEFOXITIN SODIUM EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CEFOXITIN SODIUM EQ 2GM BASE/VIAL · InjectableANDA062757-002 · Discontinued
- CEFOXITIN SODIUM EQ 1GM BASE/VIAL · InjectableANDA062757-001 · Discontinued
- CEFOXITIN SODIUM EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050517-003 · Discontinued
- CEFOXITIN SODIUM EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableThis page
- CEFOXITIN SODIUM EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050517-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050517.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Mefoxin
- Active substance
- cefoxitin sodium
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Pharmobedient
- Status
- Discontinued
- FDA approval
- 18 Oct 1978
- Application
- NDA050517-001